Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin

NCT02970032 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02970032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02970032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Completed
Start date
November 10, 2016
Completion date
December 8, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep-venous thrombosis, pulmonary embolism, venous thromboembolism